Page last updated: 2024-08-22

phenethyl isothiocyanate and Kahler Disease

phenethyl isothiocyanate has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J1

Other Studies

1 other study(ies) available for phenethyl isothiocyanate and Kahler Disease

ArticleYear
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
    Haematologica, 2011, Volume: 96, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Isothiocyanates; Mice; Mice, SCID; Multiple Myeloma; Signal Transduction; Stromal Cells; Sulfoxides; Thiocyanates; Tumor Burden; Xenograft Model Antitumor Assays

2011